Literature DB >> 4065142

In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.

S Freeman, J Wormuth, J Cornett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4065142     DOI： 10.1007/BF02014440

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system.

Authors:  G L Ridgway; J M Owen; J D Oriel
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

2.  Amifloxacin distribution in the dog prostate.

Authors:  P C Frimodt-Møller; T Dørflinger; P O Madsen
Journal:  Prostate       Date:  1985       Impact factor: 4.104

3.  The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.

Authors:  G L Ridgway; G Mumtaz; F G Gabriel; J D Oriel
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

4.  [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].

Authors:  P Cantet; H Renaudin; C Quentin; C Bebear
Journal:  Pathol Biol (Paris)       Date:  1983-06

5.  Simple, direct broth-disk method for antibiotic susceptibility testing of Ureaplasma urealyticum.

Authors:  M S Spaepen; R B Kundsin
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191
  5 in total
  5 in total

1.  Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.

Authors:  G E Kenny; T M Hooton; M C Roberts; F D Cartwright; J Hoyt
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

Review 2.  Antimicrobial chemotherapy of chlamydial infection: where next?

Authors:  G L Ridgway
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

3.  In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.

Authors:  P M Furneri; G Bisignano; G Cerniglia; G Nicoletti; M Cesana; G Tempera
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

4.  In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.

Authors:  K B Waites; L B Duffy; T Schmid; D Crabb; M S Pate; G H Cassell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 5.  Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1986-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.